Catalyst Funds Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-23,100
Closed -$13.4K 1358
2024
Q3
$13.4K Hold
23,100
﹤0.01% 1144
2024
Q2
$14.3K Buy
+23,100
New +$19.5K ﹤0.01% 800

Other funds holding GRTS

Catalyst Funds Management's GRTS Position: Q4 2024 in Review

Catalyst Funds Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 23,100 shares — an estimated $13.4K sold.

Catalyst Funds Management first reported a position in GRTS in Q2 2024 and held it in 2 quarters. The position peaked at $14.3K in Q2 2024. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • Catalyst Funds Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 23,100 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $13.4K.
  • Catalyst Funds Management first reported a position in Gritstone bio, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Gritstone bio, Inc. Common Stock position peaked at $14.3K in Q2 2024.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.